Search For Lab Tests Here

The Lyme Disease Antibody Test with Reflex to Blot IgG IgM screens for antibodies to Borrelia burgdorferi, the bacteria that cause Lyme disease. If results are positive or equivocal, a Western blot IgG/IgM is reflexively performed for confirmation. Doctors order this test for patients with tick exposure, rash, joint pain, or neurological symptoms. Results help confirm infection, guide treatment decisions, and support early detection to prevent complications.

The Lyme Disease IgG IgM Antibodies Immunoblot Test detects antibodies to Borrelia burgdorferi, the bacteria causing Lyme disease. IgM indicates recent infection, while IgG suggests past or ongoing infection. Doctors order this test to confirm exposure after ELISA screening or when symptoms such as rash, fatigue, joint pain, or neurological issues appear. Results provide critical insight for diagnosing and managing Lyme disease with greater accuracy.

The Lyme Disease IgG Antibody Immunoblot Test confirms exposure to Borrelia burgdorferi, the bacteria that cause Lyme disease. It detects IgG antibodies, which usually appear weeks after infection and remain present for months to years. Doctors use this test to confirm a positive screening result, evaluate late-stage Lyme symptoms, and support diagnosis in patients with joint pain, fatigue, or neurological complications from suspected Lyme disease.

The Lyme Disease DNA Qualitative Blood Test detects genetic material from Borrelia burgdorferi, the bacteria that cause Lyme disease. This test identifies active infection by analyzing bacterial DNA in the blood. Doctors use it to confirm Lyme disease in patients with symptoms such as fever, fatigue, or joint pain, particularly after tick exposure. It supports early diagnosis and guides treatment to prevent long-term complications.

The Babesia microti IgG IgM Antibodies Test detects antibodies to the parasite that causes babesiosis, a tick-borne infection affecting red blood cells. IgM indicates recent or active infection, while IgG suggests past or ongoing exposure. Doctors use this test to diagnose babesiosis in patients with fever, chills, anemia, or fatigue, and to differentiate it from Lyme disease or other tick-borne illnesses for accurate treatment.

The Ehrlichia chaffeensis IgG IgM Antibodies Test detects immune response to the bacterium responsible for human monocytic ehrlichiosis (HME). Measuring both IgM and IgG provides information on recent or past infection, helping identify acute illness or prior exposure. This blood test supports evaluation of tick-borne disease in patients with symptoms such as fever, fatigue, or cytopenias, guiding clinical assessment and patient management.

The Bartonella Species IgG IgM Antibodies with Reflex to Titer Test detects antibodies to Bartonella, the bacteria that cause cat scratch disease and other infections. IgM suggests recent infection, while IgG indicates past or ongoing exposure. If positive, titers confirm antibody levels. Doctors use this test to evaluate patients with fever, swollen lymph nodes, or suspected vector-borne illness, helping confirm diagnosis and guide treatment.

The Immunoglobulin G (IgG) Test measures IgG antibody levels in blood to assess immune system function and long-term response to infections. Low IgG may indicate immune deficiencies or recurrent infections, while high levels may signal chronic inflammation, autoimmune disease, or certain infections. Doctors use this test to evaluate unexplained illness, monitor immune disorders, or assess overall immunity. Results provide vital insight into immune health and disease management.

The Syphilis RPR Test screens for syphilis by detecting nonspecific antibodies produced in response to Treponema pallidum. If positive, a reflex titer is performed to measure antibody levels and monitor disease activity. Doctors use this blood test to confirm infection, determine stage, and track treatment response. It is widely used for STD screening, prenatal care, and early detection to prevent complications and transmission.

The Syphilis FTA-ABS Test (Fluorescent Treponemal Antibody Absorption) detects antibodies specific to Treponema pallidum, the bacteria that cause syphilis. Doctors use this confirmatory test after a positive screening to verify infection, even in late or latent stages. Results help distinguish syphilis from false positives, guiding diagnosis, treatment, and follow-up. This test is essential for accurate detection and long-term monitoring of syphilis.

The Syphilis Test is an RPR Test with Reflex to Titer and Confirmatory Testing that screens for antibodies to Treponema pallidum. If reactive, additional testing confirms infection and measures antibody levels to assess disease activity. Doctors use this blood test to diagnose syphilis, determine stage, and monitor treatment response. It is widely used in STD screening, prenatal care, and early detection to prevent complications and transmission.

The RPR Test with Reflex to Titer and Confirmatory Testing screens for syphilis by detecting non-treponemal antibodies. If reactive, results are automatically followed by a titer to measure antibody concentration and confirmatory treponemal testing for accuracy. Doctors use this test to diagnose active or past syphilis, monitor treatment, or screen at-risk patients. Results provide vital insight into infection status, disease stage, and overall sexual health.